Conference Coverage

Warfarin use linked to knee and hip replacement in osteoarthritis patients

Publish date: November 7, 2020

 

FROM ACR 2020

SOURCE: Ballal P et al. Arthritis Rheumatol. 2020;72(suppl 10): Abstract 0934.

Pages

Recommended Reading

FDA: Continue Study of Antinerve Growth Factors for Pain
MDedge Hematology and Oncology
FDA Approves REMS for Long-Acting Opioids
MDedge Hematology and Oncology
VIDEO: Use fiduciary duty to set pain medication boundaries
MDedge Hematology and Oncology
VIDEO: Consistency is key to monitoring patients on opioids
MDedge Hematology and Oncology
Glucocorticoids increase risk of S. aureus bacteremia
MDedge Hematology and Oncology
FDA: New labeling warns against combining opioids, benzodiazepines
MDedge Hematology and Oncology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Hematology and Oncology
Hemophilia carriers face elevated risk of joint comorbidities
MDedge Hematology and Oncology
Advice on treating rheumatic diseases from a COVID-19 epicenter
MDedge Hematology and Oncology
New ‘atlas’ maps links between mental disorders, physical illnesses
MDedge Hematology and Oncology